Percorrendo por Autor DE VELASCO, GUILLERMO
Mostrando regs. 1 a 7 de 7
Data de publicação | Título | Autor(es) |
2017 | Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials | MOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al |
2017 | Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials | MOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al |
2017 | Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model | DE VELASCO, GUILLERMO; CULHANE, AEDÍN C.; André Poisl Fay, et al |
2016 | Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma | DE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, et al |
2016 | Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma | DE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, et al |
2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al |
2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al |